問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberARGX-113-2007

2022-11-01 - 2028-04-30

Phase II/III

Recruiting3

ICD-10M33.00

Juvenile dermatopolymyositis, organ involvement unspecified

ICD-10M33.09

Juvenile dermatopolymyositis with other organ involvement

ICD-10M33.10

Other dermatopolymyositis, organ involvement unspecified

ICD-10M33.19

Other dermatopolymyositis with other organ involvement

ICD-10M33.90

Dermatopolymyositis, unspecified, organ involvement unspecified

ICD-10M33.99

Dermatopolymyositis, unspecified with other organ involvement

ICD-10M36.0

Dermato(poly)myositis in neoplastic disease

ICD-9710.3

Dermatomyositis

xxxxxx

  • Trial Applicant

    ICON Clinical Research Pte Ltd

  • Sponsor

    argenx BV

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/11/13

Investigators and Locations

Principal Investigator 梁培英 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Joung-Liang Lan 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

xxxxxx

Objectives

xxxxxx

Test Drug

Efgartigimod PH20 SC

Active Ingredient

Efgartigimod

Dosage Form

Subcutaneous Injection

Dosage

180 mg/mL

Endpoints

xxxxxx

Inclution Criteria

xxxxxx

Exclusion Criteria

xxxxxx

The Estimated Number of Participants

  • Taiwan

    11 participants

  • Global

    240 participants